ArticleBMC genomics2025
AoUPRS: A cost-effective and versatile PRS calculator for the All of Us Program.
Article in BMC genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Integrating social determinants of health and genetic risk in disease risk models.American journal of human genetics · 2026Article
- Development and External Validation of a Machine Learning Model for 10-Year Ischemic Stroke Risk Prediction in Diverse Populations.medRxiv : the preprint server for health sciences · 2026Article
- Population-Specific Genetic and Non-Genetic Influences on Sleep Traits and Health Outcomes.ArXiv · 2026Article
- Where risk becomes visible: a layered fixed-policy framework for diabetic kidney disease screening in type 2 diabetes.medRxiv : the preprint server for health sciences · 2026Article
- Article
- A deep ensemble encoder network method for improved polygenic risk score prediction.BioData mining · 2026Article
- A Scalable Framework to Integrate Social Determinants of Health into Disease Risk Models using Biobank Survey Data.medRxiv : the preprint server for health sciences · 2025Article
- Integrating Polygenic Risk Scores (PRS) for Personalized Diabetes Care: Advancing Clinical Practice with Tailored Pharmacological Approaches.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2025Review
Corrections and comments
- Update of
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe All of Us (AoU) Research Program provides a comprehensive genomic dataset to accelerate health research and medical breakthroughs. Despite its potential, researchers face significant challenges, including high costs and inefficiencies associated with data extraction and analysis. AoUPRS addresses these challenges by offering a versatile and cost-effective tool for calculating polygenic risk scores (PRS), enabling both experienced and novice researchers to leverage the AoU dataset for large-scale genomic discoveries.
methodsWe evaluated three PRS models from the PGS Catalog (coronary artery disease, atrial fibrillation, and type 2 diabetes) using two distinct approaches in the Hail framework: MatrixTable (MT), a dense representation, and Variant Dataset (VDS), a sparse representation optimized for large-scale genomic data. Computational cost, resource usage, and processing time were compared. To assess the similarity of PRS performance between these two approaches, we compared odds ratios (ORs) and area under the curve (AUC). Lin's concordance correlation coefficient (CCC) was also computed to quantify agreement between PRS scores generated by MT and VDS.
resultsThe VDS approach reduced computational costs by up to 99.51% (e.g., from $32 to $0.036 for a 51-SNP score) while maintaining PRS estimates that were highly similar to those obtained using the MT approach. Across all three PRS models, AUC comparisons showed minimal differences between MT and VDS, indicating that both approaches yield consistent PRS performance. Agreement between PRS scores calculated by both approaches was further supported by Lin's CCC values ranging from 0.9199 to 0.9944, confirming strong concordance. Empirical cumulative distribution function (ECDF) plots further illustrated the near-identical distribution of PRS values across methods.
conclusionsAoUPRS enables efficient and cost-effective PRS computation within AoU, providing substantial cost savings while maintaining highly consistent PRS estimates. These findings support the use of AoUPRS for large-scale genomic risk assessment, making the AoU dataset more accessible and practical for diverse research applications. The tool's open-source availability on GitHub, coupled with detailed documentation and tutorials, ensures accessibility and ease of use for the scientific community.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.